APERLURI Trademark

Trademark Overview

On Wednesday, March 1, 2017, a trademark application was filed for APERLURI with the United States Patent and Trademark Office. The USPTO has given the APERLURI trademark a serial number of 87354945. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, October 12, 2020. This trademark is owned by PTC Therapeutics, Inc.. The APERLURI trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of genetic disorders
aperluri

General Information

Serial Number87354945
Word MarkAPERLURI
Filing DateWednesday, March 1, 2017
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, October 12, 2020
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 11, 2017

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of genetic disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, March 8, 2017
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NamePTC Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSouth Plainfield, NJ 07080
Party NamePTC Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSouth Plainfield, NJ 07080

Trademark Events

Event DateEvent Description
Tuesday, October 13, 2020ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, October 12, 2020ABANDONMENT - NO USE STATEMENT FILED
Friday, February 14, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, February 13, 2020EXTENSION 5 GRANTED
Monday, February 10, 2020EXTENSION 5 FILED
Thursday, February 13, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, February 10, 2020TEAS EXTENSION RECEIVED
Thursday, August 29, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, August 27, 2019EXTENSION 4 GRANTED
Tuesday, August 27, 2019EXTENSION 4 FILED
Tuesday, August 27, 2019TEAS EXTENSION RECEIVED
Wednesday, March 6, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, March 4, 2019EXTENSION 3 GRANTED
Monday, March 4, 2019EXTENSION 3 FILED
Monday, March 4, 2019TEAS EXTENSION RECEIVED
Wednesday, August 29, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, August 27, 2018EXTENSION 2 GRANTED
Monday, August 27, 2018EXTENSION 2 FILED
Monday, August 27, 2018TEAS EXTENSION RECEIVED
Wednesday, August 15, 2018ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, August 15, 2018TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, February 16, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, February 14, 2018EXTENSION 1 GRANTED
Wednesday, February 14, 2018EXTENSION 1 FILED
Wednesday, February 14, 2018TEAS EXTENSION RECEIVED
Wednesday, February 14, 2018TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, September 5, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, July 11, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 11, 2017PUBLISHED FOR OPPOSITION
Wednesday, June 21, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, May 30, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, May 24, 2017ASSIGNED TO EXAMINER
Wednesday, March 8, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, March 4, 2017NEW APPLICATION ENTERED IN TRAM

Related Keywords

aperluri disorders genetic treatment preparations pharmaceutical